LEBSA- Your strategic API source for niche molecules.
01 1LABORATORIOS ESPINOS Y BOFILL SA (LEBSA)
02 1Glaxo Operations UK Ltd (Trading as Glaxo Wellcome Operations)
01 1GlaxoSmithKline Inc.
02 1Jimax Pharmachem Co., Ltd.
01 2Lacidipine
01 1Spain
02 1United Kingdom
Registrant Name : Jimax Pharmachem Co., Ltd.
Registration Date : 2022-02-16
Registration Number : 20220216-209-J-1188
Manufacturer Name : LABORATORIOS ESPINOS Y BOFIL...
Manufacturer Address : Ctra. De L'Hospitalet, 34 08940 Cornellà De Llobregat, Barcelona, Spain
Registrant Name : GlaxoSmithKline Inc.
Registration Date : 2021-05-13
Registration Number : 20210513-209-J-988
Manufacturer Name : Glaxo Operations UK Ltd (Tra...
Manufacturer Address : Cobden Street, Montrose, Angus, DD10 8EA, United Kingdom
A Lacidipine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lacidipine, including repackagers and relabelers. The FDA regulates Lacidipine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lacidipine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lacidipine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lacidipine supplier is an individual or a company that provides Lacidipine active pharmaceutical ingredient (API) or Lacidipine finished formulations upon request. The Lacidipine suppliers may include Lacidipine API manufacturers, exporters, distributors and traders.
click here to find a list of Lacidipine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Lacidipine Drug Master File in Korea (Lacidipine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Lacidipine. The MFDS reviews the Lacidipine KDMF as part of the drug registration process and uses the information provided in the Lacidipine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Lacidipine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Lacidipine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Lacidipine suppliers with KDMF on PharmaCompass.
LOOKING FOR A SUPPLIER?